Charles Casamento
@charlescasamento
Director
Building GT Biopharma, Inc. as Director
- Website not added yet
- LinkedIn not added yet
- X not added yet
- Instagram not added yet
- Facebook not added yet
Founder Rating
1500
Everyone starts at 1500.
It only moves when two founders agree to a duel.
In context
Eton Pharmaceuticals, Inc. was founded in 2017 and has no closure on record.
Named alongside
- Andrew BollDirector
- Charles J CasamentoDirector
- Mark BaumDirector
- Mark L. BaumDirector
- Norbert G RiedelDirector
- PAUL V. MAIERDirector
- Sean BrynjelsenExecutive Officer, Director
- William Wilson TroutmanExecutive Officer
- Alastair M. RiddellDirector
- Alastair RiddellDirector
- Anna SkowronExecutive Officer
- Charles M. CasamentoDirector
- Daniel DupretExecutive Officer
- Daniel SchneidermanExecutive Officer
- David HoffmanDirector
- ED BORKOWSKIDirector
- Alan UrbanExecutive Officer
- Andrew RitterDirector
- Anthony CataldoExecutive Officer, Director
- Anthony J. CataldoDirector
- Bruce WendelDirector
- Geoffrey B. DavisDirector
- Hilary KramerDirector
- Jon B. BonfiglioDirector
- Chuck EnceChief Financial Officer
- Maged ShenoudaDirector
- Ottavio VitoloExecutive Officer
- Paul KellyDirector
- Sergio TraversaExecutive Officer, Director
Contribution
Charles's ideas, decisions and failures appear here once this profile is claimed.
Companies
- GT Biopharma, Inc.Pharmaceutical Preparations; listed on Nasdaq as GTBP; filing with the SEC since 1995Director · Biotechnology · SAN FRANCISCO, United States
- Eton Pharmaceuticals, Inc.Pharmaceutical Preparations; listed on Nasdaq as ETON; filing with the SEC since 2017Director · Pharmaceuticals · SAN DIEGO, United States · Founded 2017
- GridAI Technologies Corp.Electric & Other Services Combined; formerly Entero Therapeutics, Inc.; listed on Nasdaq as GRDX; filing with the SEC since 2014Director · Pharmaceuticals · BOCA RATON, United States
- RELMADA THERAPEUTICS, INC.Pharmaceutical Preparations; formerly CAMP NINE, INC.; listed on Nasdaq as RLMD; filing with the SEC since 2012Director · Biotechnology · NEW YORK, United States